CureVac
Roland Böttger is a Senior Research Scientist and Team Lead at CureVac, where leadership of a cross-functional team focuses on advancing mRNA-LNP development and formulating LNPs for infectious disease applications. With extensive experience in mRNA delivery systems, including research on infectious diseases and cancer immunization, Roland holds multiple patents and publications. Previous roles include postdoctoral research at The University of British Columbia, intern at Precision NanoSystems Inc., and doctoral research at the University of Leipzig, complemented by a solid educational background in chemistry, culminating in an ongoing MBA at HHL Leipzig Graduate School of Management.
This person is not in any teams
This person is not in any offices
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.